FDA releases annual update on medical countermeasures initiative
The Food and Drug Administration last week reported on its fiscal year 2022 activities to support medical countermeasures, as required by the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013. The report reviews the agency’s activities to protect the nation from chemical, biological, radiological, nuclear and emerging infectious disease threats.
Related News Articles
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Headline
The AHA will make a donation to the Indiana Hospital Association in support of hospital personnel impacted by the recent flooding in Indiana caused by severe…
Headline
The Centers for Disease Control and Prevention yesterday announced that the ongoing cyclosporiasis outbreak linked to iceberg lettuce has expanded to 15 states…
Headline
The Centers for Disease Control and Prevention July 28 reported 18,207 confirmed or suspected cases of cyclosporiasis across the U.S. from the current outbreak…
Headline
Angela Hewlett, M.D., professor of infectious diseases at the University of Nebraska Medical Center and medical director of the Nebraska Biocontainment Unit,…
Headline
The Utah measles outbreak has increased to 583 cases, the state’s Department of Health and Human Services reported April 7. Of those, 386 cases have been…